TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.

Elizabeth S Duke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.